These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 26469082
1. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. Yeung BH, Shek FH, Lee NP, Wong CK. PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082 [Abstract] [Full Text] [Related]
2. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ. Oncotarget; 2016 Jan 26; 7(4):4279-97. PubMed ID: 26701853 [Abstract] [Full Text] [Related]
3. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X. Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241 [Abstract] [Full Text] [Related]
4. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J. Oncotarget; 2015 Jun 30; 6(18):16106-19. PubMed ID: 25965830 [Abstract] [Full Text] [Related]
5. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression. Cheng Q, Yuan F, Lu F, Zhang B, Chen T, Chen X, Cheng Y, Li N, Ma L, Tong T. Oncotarget; 2015 Mar 10; 6(7):4733-44. PubMed ID: 25749381 [Abstract] [Full Text] [Related]
6. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY. Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663 [Abstract] [Full Text] [Related]
7. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression. Duan M, Wang ZC, Wang XY, Shi JY, Yang LX, Ding ZB, Gao Q, Zhou J, Fan J. Ann Surg Oncol; 2015 Sep 01; 22(9):3121-9. PubMed ID: 25465376 [Abstract] [Full Text] [Related]
8. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K. Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151 [Abstract] [Full Text] [Related]
9. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM. Oncotarget; 2015 Nov 10; 6(35):37808-23. PubMed ID: 26498692 [Abstract] [Full Text] [Related]
10. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M, Li M, Wang T, Linghu E, Wu B. Tumour Biol; 2016 Oct 10; 37(10):13995-14008. PubMed ID: 27492460 [Abstract] [Full Text] [Related]
11. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518 [Abstract] [Full Text] [Related]
12. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S, Li J, Wang X. Tumour Biol; 2016 Oct 01; 37(10):14059-14067. PubMed ID: 27507614 [Abstract] [Full Text] [Related]
13. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Iwama A, Yokosuka O. Int J Cancer; 2015 Jan 15; 136(2):289-98. PubMed ID: 24844570 [Abstract] [Full Text] [Related]
14. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC. Oncol Rep; 2013 Sep 15; 30(3):1275-84. PubMed ID: 23836295 [Abstract] [Full Text] [Related]
15. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. Tumour Biol; 2016 Oct 15; 37(10):13521-13531. PubMed ID: 27465557 [Abstract] [Full Text] [Related]
16. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G, Hu S, Zhang D, Wu P, Zhu X, Xin S, Lu G, Ding Y, Liang L. Exp Mol Pathol; 2015 Oct 15; 99(2):374-82. PubMed ID: 26112097 [Abstract] [Full Text] [Related]
17. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway. Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC. Cancer Lett; 2017 Sep 10; 403():330-338. PubMed ID: 28688970 [Abstract] [Full Text] [Related]
18. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J. Anat Rec (Hoboken); 2013 Oct 10; 296(10):1568-75. PubMed ID: 23878061 [Abstract] [Full Text] [Related]
19. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H. Carcinogenesis; 2014 Dec 10; 35(12):2748-55. PubMed ID: 25280563 [Abstract] [Full Text] [Related]
20. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T, Huang C. Oncotarget; 2015 Jun 30; 6(18):16227-38. PubMed ID: 26023735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]